Gilead Sciences Financial Health
How is Gilead Sciences's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: GILD's short term assets ($13.6B) exceed its short term liabilities ($10.4B).
Long Term Liabilities: GILD's short term assets ($13.6B) do not cover its long term liabilities ($31.1B).
Debt to Equity History and Analysis
Debt Level: GILD's net debt to equity ratio (90.2%) is considered high.
Reducing Debt: GILD's debt to equity ratio has increased from 116.3% to 119.8% over the past 5 years.
Debt Coverage: GILD's debt is well covered by operating cash flow (38.5%).
Interest Coverage: GILD's interest payments on its debt are well covered by EBIT (11.3x coverage).